Harald Ohmer

Title: The Innovative Mind of Harald Ohmer

Introduction

Harald Ohmer, an inventive scientist based in Singen, Germany, has made notable contributions to the field of pharmaceutical chemistry. With a focus on innovative compounds, he has secured recognition through his patent, which highlights his expertise in developing effective inhibitors for specific enzymes.

Latest Patents

Ohmer holds a patent for the invention titled "3,4,4a,10b-Tetrahydro-1H-thiopyrano-[44,3-c] isoquinoline derivatives." This patent encompasses compounds that are novel and significant in their potential to inhibit type 4 and 5 phosphodiesterase. The detailed formulations consist of specific elements represented by Formula (1), where A, R1, R2, R3, and R5 are defined in the patent description, showcasing the effectiveness of these compounds in therapeutic applications.

Career Highlights

Harald Ohmer is associated with Takeda GmbH, a prominent company in the pharmaceutical sector. His career has been marked by a commitment to innovation and the development of compounds that address critical health issues. Through his research, he has contributed to advancing the field of pharmacology, demonstrating his dedication to improving patient outcomes.

Collaborations

Throughout his career, Ohmer has collaborated with esteemed colleagues, including Dieter Flockerzi and Thomas Stengel. These collaborations have likely played a significant role in enhancing his research endeavors, fostering a productive environment for innovation and discovery within the pharmaceutical sphere.

Conclusion

In conclusion, Harald Ohmer stands out as an influential inventor in the realm of pharmaceuticals, with his patent representing a significant step forward in the development of enzyme inhibitors. His work at Takeda GmbH, along with his collaborations, reinforces his status as a key contributor to scientific research and innovation, paving the way for future advancements in the field.